Market Overview

UPDATE: Jefferies Raises PT on Cerner Corporation on Competitive Inroads

Share:
Related CERN
Cerner to Replace Department of Defense's Anatomic Pathology Laboratory Information System
Healthcare IT Investors: Oppenheimer Just Made Some Waves
Will Cerner's (CERN) Earnings Pull a Surprise in Q2? - Analyst Blog (Zacks)

In a report published Friday, Jefferies analyst David Windley reiterated a Buy rating on Cerner Corporation (NASDAQ: CERN), and raised the price target from $97.00 to $110.00.

In the report, Windley noted, “In recent presentations, KLAS (HCIT independent rating org) described current competitive trends in the EHR space, and Premier (GPO) members forecasted continued high IT spending. Epic is still the dominant player, but CERN is making competitive inroads with decision makers; raising CERN PT to $110. ATHN has higher stickiness and promoter scores than industry averages. MDRX has fallen off clients' radars, and has a lot of work to do.”

Cerner Corporation closed on Thursday at $95.54.

Latest Ratings for CERN

DateFirmActionFromTo
Jun 2015OppenheimerInitiates Coverage onOutperform
Apr 2015SunTrust Robinson HumphreyDowngradesBuyNeutral
Apr 2015BarclaysMaintainsBuy

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CERN)

Get Benzinga's Newsletters